首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8263篇
  免费   887篇
  国内免费   10篇
耳鼻咽喉   74篇
儿科学   217篇
妇产科学   133篇
基础医学   1133篇
口腔科学   293篇
临床医学   973篇
内科学   1654篇
皮肤病学   115篇
神经病学   603篇
特种医学   302篇
外科学   1231篇
综合类   226篇
一般理论   6篇
预防医学   834篇
眼科学   209篇
药学   641篇
中国医学   2篇
肿瘤学   514篇
  2021年   94篇
  2020年   71篇
  2019年   111篇
  2018年   126篇
  2017年   128篇
  2016年   131篇
  2015年   137篇
  2014年   150篇
  2013年   253篇
  2012年   363篇
  2011年   391篇
  2010年   241篇
  2009年   221篇
  2008年   324篇
  2007年   359篇
  2006年   349篇
  2005年   379篇
  2004年   301篇
  2003年   357篇
  2002年   308篇
  2001年   256篇
  2000年   285篇
  1999年   239篇
  1998年   107篇
  1997年   113篇
  1996年   104篇
  1995年   99篇
  1994年   111篇
  1993年   101篇
  1992年   200篇
  1991年   175篇
  1990年   166篇
  1989年   168篇
  1988年   165篇
  1987年   164篇
  1986年   144篇
  1985年   168篇
  1984年   116篇
  1983年   105篇
  1982年   78篇
  1981年   74篇
  1980年   63篇
  1979年   111篇
  1978年   70篇
  1977年   77篇
  1973年   85篇
  1972年   74篇
  1971年   73篇
  1970年   61篇
  1968年   59篇
排序方式: 共有9160条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
The MMPI was administered during the patient-perceived best time of the menstrual cycle and during the patient-perceived worst time of the cycle in order to examine the stability of MMPI profile configurations. Subjects were 214 women who were referred to two metropolitan outpatient premenstrual syndrome (PMS) clinics for moderate to severe premenstrual complaints. This sample was selected from 1,849 intake files after screening by strict selection criteria for PMS. The results indicate that there are wide fluctuations in profile patterns between the best and worst times of the menstrual cycle for a large number of patients. Caution in using the MMPI is strongly advised.  相似文献   
7.
8.
Summary Cytosine arabinsodie (ara-C) and etoposide (VP-16) display synergy in the laboratory. Twenty-six patients participated in a phase I study of high-dose ara-C in combination with VP-16. The dose of VP-16 was held constant at 50 mg/m2 as an intermittent infusion over 33 h; escalating doses of ara-C were given as infusions during hours 9–12 and 21–24. Myelosuppression was the dose-limiting toxicity and occurred with doses considerably less than those expected from studies of the two drugs as single agents. The suggested initial doses for phase II trials with this schedule are 750 mg/m2×2 doses of ara-C and 50 mg/m2 of VP-16. Nonhematologic toxicity was minimal; therefore, further dose escalation is feasible in patients in whom myelosuppression is acceptable.Supported in part by grants from the National Cancer Institute (CA-12197 and CA-09422) and the American Cancer Society CF-85-182  相似文献   
9.
青蒿琥酯皮肤擦剂在小鼠和兔体内的药代动力学研究   总被引:1,自引:0,他引:1  
赵凯存  宣文漪  赵一  宋振玉 《药学学报》1989,24(11):813-816
将青蒿琥酯溶于苯二甲酸二甲酯,加适量氨酮制成皮肤擦剂。给兔脱毛后,皮肤涂抹此擦剂25mg/kg后,血药浓度达峰时间平均为2 h,峰浓度平均为1.80μg/ml。药物在兔体内平均驻留时间为3.54 h,清除半衰期约为2.46 h。给小鼠脱毛皮肤涂抹擦剂6.7,31.3和71.4 mg/kg,血药浓度在给药后0.5~4 h达高峰,峰浓度分别为0.82,2.05和7.11μg/ml,体内药物平均驻留时间为3.39,2.79及3.54 h,清除半衰期为2.35,1.93及2.45 h。可见,给兔及小鼠皮肤擦剂后,青蒿琥酯吸收良好,血药浓度维持时间较长。  相似文献   
10.
Power spectral and discriminant analysis techniques were used to compare EEG records obtained at term and at 3 months past term from 5 groups of varying risk and developmental outcome. The groups were: healthy full-terms; healthy pre-terms with normal outcomes; sick pre-terms with normal outcomes; sick pre-terms with delayed development; sick pre-terms with later neurological problems. The EEG samples recorded at term were identified as belonging to the correct subject group at 52-70% accuracy, 20% being chance for 5 groups. The accuracy varied with the 4 classes of EEG patterns used. The individual subjects were also classified into their correct groups with few exceptions. Similar success was obtained with EEG samples selected from recording at 3 months past term. The predominant power spectral discriminating features were changes in intra- and inter-hemispheric coherence, and increased power, particularly in the middle and higher frequency range. Thus, computer analyses of EEG samples, using features not readily identified visually, differentiated risk from non-risk infants and also differentiated infants with substantial neonatal medical complications who have good or poor developmental outcomes.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号